🔎 Trials Near Me

Akèy › Adenokasinom Ezofajyen › Texas › Dallas

Etid klinik pou Adenokasinom Ezofajyen nan Dallas, TX

8 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Ap rekriteFaz 3
  • Parkland Memorial Hospital, Dallas
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05677490

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

Ap rekriteFaz 2
  • Baylor University Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06732388

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Ap rekrite
  • Baylor University Medical Center, Dallas
Laj 18 a 89 · Tout sèks · Mizajou Sep 11, 2026 · NCT05753748

A Study of KK2269 in Adult Participants With Solid Tumors

Ap rekriteFaz 1
  • The University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06266299

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Ap rekriteFaz 1
  • Normunity Investigational Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Ap rekriteFaz 1/2
  • Texas Oncology, P.A., Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Ap rekriteFaz 2
  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Nov 5, 2025 · NCT05563766

Etid Adenokasinom Ezofajyen nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.